Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Using mental imagery and scents to improve sleep in insomnia patients

Official title: Mental Imagery and Targeted Memory Reactivation in Insomnia

Run by University Hospital, Geneva · NCT06335784 · Data updated 2026-11-12

This study is testing whether using mental imagery and scents can help people with insomnia sleep better and feel less anxious.

More Insomnia Disorder trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Locations1 site (Geneva)
StatusRecruiting
StartedApril 22, 2024
Main results expectedMay 31, 2027
Study endsAugust 31, 2027
Registry record updatedMarch 3, 2026
Trial IDNCT06335784 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 45 who have been diagnosed with Insomnia Disorder and meet specific severity criteria.

Probably not a fit

Patients with other psychiatric disorders, significant medical conditions affecting sleep, or those with olfactory issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of mental Imagery Rescripting (IR) and olfactory Targeted Memory Reactivation (TMR) in reducing insomnia severity and hyperarousal in patients with Insomnia Disorder. Participants will be randomized into four groups, receiving different interventions including sleep hygiene education, IR sessions, and TMR during sleep. The aim is to transform negative memories into positive ones and strengthen memory recall to improve sleep quality. The study will assess the impact of these techniques over four weeks.

Why it matters

Potential benefit: If successful, this approach could significantly improve sleep quality and reduce insomnia symptoms in affected patients.

How similar studies have gone: While the combination of IR and TMR is innovative, similar approaches in memory reactivation have shown promise in other contexts, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 45 years
* Insomnia disorder according to the International Classification of Diseases 3 (ICSD-3)
* ISI \> 10
* PSQI \> 5
* No other current treatment for Insomnia

Exclusion Criteria:

* patients with another psychiatric disorder requiring acute treatment according to DSM-5
* patients with medical (e.g. neurological disorders) or other disorders explaining the predominant complaint of insomnia (e.g., sleep apneas with ODI\>15/h, restless legs syndrome, periodic limb movements with PLM\>15, chronic pain)
* patients with significant substance use/withdrawal
* patients with heavy smoking
* known pregnancy
* patients suffering from anosmia, olfactory related issues and respiratory pathology

Where it's running

  • Center for Sleep Medicine
    Geneva, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.